Metraipolis › archive › dc_233acf9ebe0e

From Lab to Clinic: How Artificial Intelligence (AI) Is Reshaping Drug Discovery Timelines and Industry Outcomes — Europe PMC PMID:40732273

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40732273
DOI
10.3390/ph18070981
License (as archived)
solo-consultazione
Archived
2026-10-06T19:01:55.478Z
SHA-256 of the archived text
f90bad836c1219514a99c63e3c7e3b4d229f8f675ab6a18472f132fae662a80e
Stable URL of this page
https://metraipolis.com/documento/dc_233acf9ebe0e

How to cite

From Lab to Clinic: How Artificial Intelligence (AI) Is Reshaping Drug Discovery Timelines and Industry Outcomes — Europe PMC PMID:40732273 — Europe PMC (en), https://europepmc.org/article/MED/40732273 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_233acf9ebe0e (Metraipolis archive dc_233acf9ebe0e, sha256 f90bad836c1219514a99c63e3c7e3b4d229f8f675ab6a18472f132fae662a80e)
BibTeX
@misc{dc233acf9ebe0e,
  title = {From Lab to Clinic: How Artificial Intelligence (AI) Is Reshaping Drug Discovery Timelines and Industry Outcomes — Europe PMC PMID:40732273},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40732273},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_233acf9ebe0e; sha256 f90bad836c1219514a99c63e3c7e3b4d229f8f675ab6a18472f132fae662a80e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40732273. Agents can read the archived copy with the MCP tool read_document.